MedTrace Logo

Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study)

NCT00418041 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2015-05-12

No results posted yet for this study

Summary

Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study) is a large, prospective, hospital-based cohort study to investigate the following:

* Characteristics of patients with chronic heart failure and prognostic risks of these patients.
* Characteristics of patients with high risk for heart failure and critical factors which predict the development of symptomatic heart failure in these patients.
* The incidence and prognostic impact of metabolic syndrome in patients with chronic heart failure.
* The association between metabolic syndrome and the development of symptomatic heart failure.

Conditions

  • Heart Failure
  • Coronary Disease
  • Heart Valve Diseases
  • Cardiomyopathies
  • Left Ventricular Hypertrophy

Sponsors & Collaborators

  • Hiroaki Shimokawa, MD, PhD

    lead OTHER

Principal Investigators

  • Hiroaki Shimokawa, MD, PhD · Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2019-03-31
Completion
2019-12-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00418041 on ClinicalTrials.gov